NCT00190060View on ClinicalTrials.gov

Study of The Effects of Testosterone in Frail Elderly Men

PHASE4CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
FrailtySarcopenia
Interventions
DRUG

Transdermal testosterone gel (Testogel 1% )

Transdermal testosterone gel (Testogel 1% ), 50 mg/d for 6 months

DRUG

Matched transdermal placebo gel

Matched transdermal placebo gel, 50mg/d for 6 months

Trial Locations (1)

M13 9WL

Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary, Manchester

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

University of Manchester

OTHER

collaborator

Bayer

INDUSTRY

lead

Manchester University NHS Foundation Trust

OTHER_GOV